← Back to guidelines
Dermatology13 papers

Benign hypertensive renal disease

Last edited: 4/14/2026

Overview

Benign hypertensive renal disease refers to non-malignant renal conditions often associated with hypertension, though the provided abstracts primarily focus on benign breast diseases rather than renal conditions. Relevant renal management details are not covered in the given abstracts.

Diagnosis

  • Core biopsy is essential for diagnosing benign fibroepithelial lesions (FELs) like fibroadenomas and phyllodes tumors 1.
  • Imaging follow-up is not required for core biopsy-proven concordant fibroadenomas without atypia 1.
  • Management

  • Excision of symptomatic fibroadenomas or those reaching a certain size or showing growth is recommended 1.
  • Complete excision without transection of the mass is advised when surgical removal is necessary 1.
  • Aesthetic considerations and patient preference should guide incision placement 1.
  • Special Populations

  • Pediatrics: Retroperitoneoscopic nephrectomy with modifications such as prone positioning and smaller instruments can be effective for benign renal disease in children 3.
  • Pregnancy and Lactation: Specific management guidelines for benign breast diseases during pregnancy or lactation are not detailed in the provided abstracts 2.
  • Key Recommendations

  • Core biopsy-proven concordant fibroadenomas without atypia do not require imaging follow-up and can return to routine screening schedules (Evidence: Strong 1).
  • Symptomatic fibroadenomas or those meeting size criteria or demonstrating growth should be considered for surgical excision (Evidence: Strong 1).
  • For pediatric patients, retroperitoneoscopic nephrectomy with optimized techniques can be safely employed for benign renal conditions (Evidence: Moderate 3).
  • References

    1 Rosenberger LH, White RL, Tafra L, Boughey JC, Johnson NM, Pass HA et al.. American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions. JAMA surgery 2025. link 2 . Practice Bulletin No. 164 Summary: Diagnosis and Management of Benign Breast Disorders. Obstetrics and gynecology 2016. link 3 Borer JG, Peters CA. Pediatric retroperitoneoscopic nephrectomy. Journal of endourology 2000. link 4 Forrest AP. Benign breast disease: end-points of treatment. Cancer detection and prevention 1992. link

    Original source

    1. [1]
      American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions.Rosenberger LH, White RL, Tafra L, Boughey JC, Johnson NM, Pass HA et al. JAMA surgery (2025)
    2. [2]
    3. [3]
      Pediatric retroperitoneoscopic nephrectomy.Borer JG, Peters CA Journal of endourology (2000)
    4. [4]
      Benign breast disease: end-points of treatment.Forrest AP Cancer detection and prevention (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG